Related Experiment Video
Updated: Jun 16, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute
Ann-Marie Svensson1, Darren K McGuire, Putte Abrahamsson
1Clinical Experimental Research Laboratory, Sahlgrenska University Hospital/Ostra, 416 85 Göteborg, Sweden. ann-marie.svensson@hjl.gu.se
Aims:
The study evaluated the associations between glycometabolic parameters at admission and during hospitalization and 2 year all-cause mortality risk in an unselected cohort of consecutive patients with diabetes admitted for unstable angina or non-Q-wave myocardial infarction to a university hospital during 1988-98.
Methods And Results:
A total of 713 consecutive patients with diabetes were included. During 2 years of follow-up, 242 (34%) patients died. All analyses were retrospective using prospectively collected clinical data. The primary study endpoint was 2 year all-cause mortality collected from the Swedish cause-specific mortality register. In unadjusted analyses, high admission blood glucose (highest vs. lowest quartile: hazard ratio (HR) 2.66; 95% confidence interval (CI) 1.83, 3.86) and hypoglycaemia recorded during hospitalization (hypoglycaemia vs. normal: HR 1.77; 95% CI 1.09, 2.86) were both significantly associated with increased 2 year all-cause mortality risk. These associations remained significant after multivariable adjustment.
Conclusion:
In the setting of acute coronary syndromes (ACS) among patients with diabetes, hyperglycaemia on arrival and hypoglycaemia during hospitalization are both independently associated with worse adjusted all-cause 2 year mortality risk. These observations suggest that the avoidance of both hyper- and hypoglycaemia during ACS events may be of similar importance, and glucose modulation remains an important objective to address in future randomized trials.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia and Glucagon
Type II Diabetes II: Pathophysiology
Complications of Diabetes Mellitus
Hypoglycemia
Hyperglycemia

